Genelux (GNLX) vs Quantum Cyber N.V. (QUCY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Quantum Cyber N.V. (QUCY) has outperformed Genelux (GNLX) over the past year, losing 13.1% versus a loss of 47.4%. Genelux is the larger company by market cap ($114.5 million vs $114.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GNLX | QUCY |
|---|---|---|
| Share price | $2.53 | $1.36 |
| Market cap | $114.47M | $114.33M |
| 1-day change | +1.20% | -2.16% |
| YTD return | -42.66% | +24.11% |
| 1-year return | -47.37% | -13.13% |
| EPS (TTM) | $-0.86 | $-2.41 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.54 | $4.93 |
| 52-week low | $2.29 | $0.30 |
| Distance from 52-week high | -70.36% | -72.41% |
| Analyst consensus | none | none |
| Avg. price target upside | +644.27% | +561.76% |
| Average volume | 276.16K | 691.24K |
| Shares outstanding | 45.25M | 84.07M |
| Employees | 25 | 10 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- QUCY has outperformed GNLX by 34.2 percentage points over the past year.
About Genelux
GNLX stock →Genelux Corporation, a clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types. Its lead product candidate is Olvi-Vec (olvimulogene nanivacirepvec), a proprietary modified strain of the vaccinia virus indicated for the treatment of ovarian cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 25 employees
About Quantum Cyber N.V.
QUCY stock →Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions.
Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees
GNLX vs QUCY FAQ
Which is bigger, Genelux or Quantum Cyber N.V.?
Genelux (GNLX) is larger, with a market capitalization of $114.47M compared with $114.33M for Quantum Cyber N.V. (QUCY).
Which stock has performed better over the past year, GNLX or QUCY?
QUCY returned -13.13% over the past 12 months, compared with -47.37% for GNLX (price return, excluding dividends). Past performance does not predict future results.
Are Genelux and Quantum Cyber N.V. in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.